 |
 |
I believe the article, hyped by the manufacturer, appeared in the National Enquirer. It is completely ridiculous. The drug was approved (barely) for ALS and the company now wishes to see whether it has any value for Parkinson's disease. Maybe it will; the tests will show. But miracle it ain't. robin elliott, executive director, Parkinson's disease foundation